Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmNanocarriers for vascular delivery of antioxidantsIcam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammationTargeted delivery of therapeutics to endothelium.Developmental regulation of antioxidant enzymes and their impact on neonatal lung diseaseNHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases.Tissue-protective effect of glutamine on hepatic ischemia-reperfusion injury via induction of heme oxygenase-1.Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.Targeting antioxidant and antithrombotic biotherapeutics to endothelium.Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factorTargeted modulation of reactive oxygen species in the vascular endotheliumFactors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigrationEndothelial targeting of antibody-decorated polymeric filomicelles.Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammationStreptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.Targeted detoxification of selected reactive oxygen species in the vascular endothelium.Targeted interception of signaling reactive oxygen species in the vascular endotheliumEndothelial nanomedicine for the treatment of pulmonary disease.Targeted endothelial nanomedicine for common acute pathological conditions.Targeting vascular (endothelial) dysfunction.Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery.Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation.Catalase-coupled gold nanoparticles: comparison between the carbodiimide and biotin-streptavidin methods.Modifications of microvascular EC surface modulate phototoxicity of a porphycene anti-ICAM-1 immunoconjugate; therapeutic implications.Antibody-mediated lung endothelium targeting: in vivo model on primates.Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.Targeting therapeutics to endothelium: are we there yet?The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).
P2860
Q27026630-279E2F4C-D53A-45B2-8D1E-8FCA6813C09CQ27027067-F920DE61-2255-48F2-B605-D04967DBBD90Q28540684-1D6D0597-D550-4249-B93F-DF0725B68DA0Q30475849-DEDEDEB3-B81E-4B4C-9325-BF227BCD00D3Q34371022-5C862905-4504-4E8B-ADD2-6BCC99DF5BF1Q34400936-913C2F51-1F86-404B-8B49-D1A2C0ED87E3Q34484949-073CD45F-00D7-43C7-899D-19C474087CA4Q34593961-3490DFE6-02AE-426F-9DFC-829DA0AD8BD5Q34935960-2F132697-8305-4C59-92BF-DD7D66437CC5Q35077934-2E306853-283F-40BE-8E77-F0EBA0432A92Q35098774-D89C4157-8F40-4A3F-977D-8DD4D910C7B6Q35759213-9E85FE84-4041-434C-8632-6CF3361708A7Q35788765-951D052B-6564-4B64-A528-F63474E051ECQ35930068-18B792BA-F7C1-4621-812C-8B6718877F10Q36721811-99C711D5-E858-4A62-8872-DFD87D1BB63BQ37184666-23D346A4-54B9-43AE-8D61-B86E1017808DQ37416432-7F2AD23B-0CF1-419B-9DF8-D32DBE8C77A6Q38029695-4B4FE664-9D90-4F49-B647-16A51AD0F96BQ38267984-D6B5477B-46BE-4B8A-ACCA-D95BE112768CQ38598987-9B062811-E537-452F-9E5A-04F695BAF88BQ38836199-6778D14F-1A99-4A51-9D08-1C8AD0B7F2CDQ40322222-D65B9AA1-5F66-41F9-A553-983328B1BE5EQ41351381-6B86DFC4-998F-4B79-9EBF-EAF02BB27D75Q42262325-BDFE6151-8ECF-41A6-8E53-F44502FF69C6Q42831090-C59EAA8F-D264-4FD4-BF8C-62B733AD1E53Q45884353-24E0082C-41FC-4B94-A66B-B28E67E58193Q47240067-C0995643-0F1E-4757-83E0-5F8D745150EAQ47250590-30FF9F29-0E23-4C87-BC73-7459C07A7FC7Q47675852-54D82148-810F-4528-8E12-161DA41538C7
P2860
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@en
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@nl
type
label
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@en
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@nl
prefLabel
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@en
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@nl
P2093
P2860
P356
P1476
Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
@en
P2093
A B Fisher
E N Atochina
H Ischiropoulos
S M Danilov
V R Muzykantov
P2860
P304
P356
10.1073/PNAS.93.11.5213
P407
P577
1996-05-01T00:00:00Z